Search research articles
Contact Us
Filters
Showing results (1211-1220 of 1,460) with videos related to
Page
of 146
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)
|
July 3, 2023
Adaptation of the Tumor Antigen Presentation Machinery to Ionizing Radiation
Mi-Heon Lee, Duang Ratanachan, Zitian Wang, et al.
Biorxiv : the Preprint Server for Biology
|
February 3, 2021
Antibody Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7
Pengfei Wang, Manoj S Nair, Lihong Liu, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
December 17, 2011
Targeting the vaginal mucosa with human papillomavirus pseudovirion vaccines delivering simian immunodeficiency virus DNA
Shari N Gordon, Rhonda C Kines, Galyna Kutsyna, et al.
Sustainability Science
|
March 9, 2021
Creating leadership collectives for sustainability transformations
O Care, M J Bernstein, M Chapman, et al.
The Journal of Clinical Investigation
|
October 2, 2014
HIV-specific humoral responses benefit from stronger prime in phase Ib clinical trial
Pierre-Alexandre Bart, Yunda Huang, Shelly T Karuna, et al.
Pathogens & Immunity
|
January 2, 2020
Crystal Structure and Immunogenicity of the DS-Cav1-Stabilized Fusion Glycoprotein From Respiratory Syncytial Virus Subtype B
M Gordon Joyce, Amy Bao, Man Chen, et al.
Frontiers in Immunology
|
June 17, 2021
Sequence-Signature Optimization Enables Improved Identification of Human HV6-1-Derived Class Antibodies That Neutralize Diverse Influenza A Viruses
Gwo-Yu Chuang, Chen-Hsiang Shen, Crystal Sao-Fong Cheung, et al.
Journal of Virology
|
September 2, 2016
Packaging and Prefusion Stabilization Separately and Additively Increase the Quantity and Quality of Respiratory Syncytial Virus (RSV)-Neutralizing Antibodies Induced by an RSV Fusion Protein Expressed by a Parainfluenza Virus Vector
Bo Liang, Joan O Ngwuta, Richard Herbert, et al.
Vaccine
|
March 3, 2001
QS-21 promotes an adjuvant effect allowing for reduced antigen dose during HIV-1 envelope subunit immunization in humans
T G Evans, M J McElrath, T Matthews, et al.
Research Square
|
February 3, 2021
Increased Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7 to Antibody Neutralization
Pengfei Wang, Lihong Liu, Sho Iketani, et al.
Page
of 146
Search research articles
Search
Showing results (1211-1220 of 1,460) with videos related to
Sort By:
Page
of 146
Journal of Immunology (Baltimore, Md. : 1950)
|
July 3, 2023
Adaptation of the Tumor Antigen Presentation Machinery to Ionizing Radiation
Mi-Heon Lee, Duang Ratanachan, Zitian Wang, et al.
Biorxiv : the Preprint Server for Biology
|
February 3, 2021
Antibody Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7
Pengfei Wang, Manoj S Nair, Lihong Liu, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
December 17, 2011
Targeting the vaginal mucosa with human papillomavirus pseudovirion vaccines delivering simian immunodeficiency virus DNA
Shari N Gordon, Rhonda C Kines, Galyna Kutsyna, et al.
Sustainability Science
|
March 9, 2021
Creating leadership collectives for sustainability transformations
O Care, M J Bernstein, M Chapman, et al.
The Journal of Clinical Investigation
|
October 2, 2014
HIV-specific humoral responses benefit from stronger prime in phase Ib clinical trial
Pierre-Alexandre Bart, Yunda Huang, Shelly T Karuna, et al.
Pathogens & Immunity
|
January 2, 2020
Crystal Structure and Immunogenicity of the DS-Cav1-Stabilized Fusion Glycoprotein From Respiratory Syncytial Virus Subtype B
M Gordon Joyce, Amy Bao, Man Chen, et al.
Frontiers in Immunology
|
June 17, 2021
Sequence-Signature Optimization Enables Improved Identification of Human HV6-1-Derived Class Antibodies That Neutralize Diverse Influenza A Viruses
Gwo-Yu Chuang, Chen-Hsiang Shen, Crystal Sao-Fong Cheung, et al.
Journal of Virology
|
September 2, 2016
Packaging and Prefusion Stabilization Separately and Additively Increase the Quantity and Quality of Respiratory Syncytial Virus (RSV)-Neutralizing Antibodies Induced by an RSV Fusion Protein Expressed by a Parainfluenza Virus Vector
Bo Liang, Joan O Ngwuta, Richard Herbert, et al.
Vaccine
|
March 3, 2001
QS-21 promotes an adjuvant effect allowing for reduced antigen dose during HIV-1 envelope subunit immunization in humans
T G Evans, M J McElrath, T Matthews, et al.
Research Square
|
February 3, 2021
Increased Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7 to Antibody Neutralization
Pengfei Wang, Lihong Liu, Sho Iketani, et al.
Page
of 146